SCHEMBL160803

SCHEMBL160803

CCOC(=O)c1[nH]c(=S)sc1CC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 1/20 0.57
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HPGD P15428 5/20 0.44
ALDH1A1 P00352 7/20 0.41
GAA P10253 3/20 0.41
MAPT P10636 3/20 0.41
KDM4E B2RXH2 2/20 0.41
RXFP1 Q9HBX9 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPK10 P53779 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HTT P42858 1/20 0.41
RECQL P46063 1/20 0.41
PPARG P37231 1/20 0.40
NCOA2 Q15596 1/20 0.40
POLB P06746 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL161744 0.83 MC4R (0.60) MC4RCYP1A2CYP2C9CYP2C19HPGD
SCHEMBL12418620 0.80 MC4R (0.57) MC4RCYP1A2CYP2C9CYP2C19HPGD
SCHEMBL114601 0.75 MC4R (0.51) MC4RCYP1A2CYP2C9CYP2C19HPGD
SCHEMBL1880439 0.72 MC4R (1.00) MC4RCYP1A2CYP2C9CYP2C19HPGD
SCHEMBL14706015 0.71 GRM6 (0.56) MC4RHPGDALDH1A1GAAMAPT
SCHEMBL2616850 0.68 ALDH1A1 (0.53) MC4RCYP1A2CYP2C9CYP2C19HPGD
SCHEMBL276284 0.68 CYP1A2 (0.56) MC4RCYP1A2CYP2C9CYP2C19HPGD
SCHEMBL11813944 0.68 CYP1A2 (0.44) MC4RCYP1A2CYP2C9CYP2C19HPGD
SCHEMBL167141 0.68
SCHEMBL11652356 0.68 CYP1A2 (0.80) CYP1A2CYP2C9CYP2C19HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424860-A1 HETEROARYLTHIOMETHYL PYRIDINE DERIVATIVE MSD K.K. (JP) 2012-03-07 EP disclosed
US-20120028970-A1 HETEROARYLTHIOMETHYL PYRIDINE DERIVATIVE MSD K.K. (JP) 2012-02-02 US disclosed
WO-2010126163-A1 HETEROARYLTHIOMETHYL PYRIDINE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028970-A1 HETEROARYLTHIOMETHYL PYRIDINE DERIVATIVE AR, NR5A1, ARL1 MC4R 313/4885CYP1A2 126/4885CYP2C9 1044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.